Company / SG&A per Share
GYRE THERAPEUTICS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.24
FY2025
5-year range
$0.21 / $0.86
FY2021-FY2025
Trend
+14.6%
vs FY2024
Sector context
#196 of 210
Health Care
What the data says
Among 210 Health Care companies, GYRE THERAPEUTICS, INC. is in the top 7% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $0.21 in FY2024 to $11.89 in FY2016.
Based on SEC 10-K filings.
0.24 in FY2025 with a 5-year CAGR of -26.4%.
Improved from $0.27 to $0.24 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- -26.4%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 210This company $0.24 Sector average $29.50
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 14.6% year-over-year.
- Ranks #196 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2016.
- Lowest sg&a per share in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.24 | +14.6% |
| FY2024 | $0.21 | -23.0% |
| FY2023 | $0.27 | +19.0% |
| FY2022 | $0.23 | -73.3% |
| FY2021 | $0.86 | -23.0% |
| FY2020 | $1.11 | -0.7% |
| FY2019 | $1.12 | -31.7% |
| FY2018 | $1.64 | -43.7% |
| FY2017 | $2.92 | -75.4% |
| FY2016 | $11.89 | -63.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026